Synaptogenix Inc (SNPX)

[Cyosol]

If they run out of cash the shares become worthless. That's why dilution is the better option.

Every startup will raise new capital by issuing shares until they start earning profits, and this one is no exception.

When the price dips below $1 they'll do another reverse split to keep the listing and then continue diluting until they figure out a way to make money.

Maybe the posthoc analysis will give them a reason to do another AD trial, but even then you'll have to wait another 3 years or so before they finish that trial and announce new results.